Vistin Pharma ASA (OSL:VISTN) ROCE % : 33.30% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vistin Pharma ASA's annualized ROCE % for the quarter that ended in Dec. 2024 was 33.30%.

Vistin Pharma ASA ROCE % Historical Data

The historical data trend for Vistin Pharma ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA ROCE % Chart

Vistin Pharma ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-34.26

11.12

-1.33

28.69

29.08

Vistin Pharma ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															34.33	21.70	32.94	32.70	33.30

Vistin Pharma ASA ROCE % Calculation

Vistin Pharma ASA's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	94.705	/	( ( (403.396 - 69.473)	+	(384.945 - 67.481) )	/ 2 )
	=	94.705	/	( (333.923	+	317.464)	/ 2 )
	=	94.705	/	325.6935
	=	29.08 %

Vistin Pharma ASA's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	106.244	/	( ( (387.944 - 67.398)	+	(384.945 - 67.481) )	/ 2 )
	=	106.244	/	( ( 320.546	+	317.464 )	/ 2 )
	=	106.244	/	319.005
	=	33.30 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Vistin Pharma ASA (OSL:VISTN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vistin Pharma ASA ROCE % Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vistin Pharma ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSL:VISTN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0RAM:UK VP4:Germany

Address

Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661

Website

https://www.vistin.com

Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines